Beneficial gut microbiome increase and harmful ones getting controlled after 60 day consumption of Neu REFIX in a clinical study undertaken jointly with Multiple Sclerosis Society of India was chosen as the best presentation (https://www.linkedin.com/feed/update/urn:li:activity:7057903323974176768/) in the meeting jointly hosted with Japanese Society of Probiotic Science (JSPS).
The clinical study outcome has been selected for a presentation in the Consortium of Multiple Sclerosis Centers annual conference to be held in Colarado USA between 29 May ~ 02 June 2023.
